Polkadot price fluctuated in a tight range near $1.50 on Tuesday. Bulls could push to above $1.67 ahead of DOT emissions cut. Sell-off pressure amid prevailing Polkadot price fluctuated in a tight range near $1.50 on Tuesday. Bulls could push to above $1.67 ahead of DOT emissions cut. Sell-off pressure amid prevailing

Polkadot price outlook: bulls test key resistance near $1.50

2026/03/10 20:39
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]
  • Polkadot price fluctuated in a tight range near $1.50 on Tuesday.
  • Bulls could push to above $1.67 ahead of DOT emissions cut.
  • Sell-off pressure amid prevailing market conditions might derail this setup.

Polkadot is trading near $1.50 as bulls position amid a potential breakout, with eyes on the upcoming upgrade and overhaul of DOT’s tokenomics.

The cryptocurrency’s price is also off lows of $1.40 reached earlier in the week as investors ponder a potential boost to DOT from fresh institutional interest.

Bulls recently celebrated the launch of the first US spot Polkadot ETF.

DOT, ranked 33rd with a market capitalization of $2.54 billion, is bidding to extend gains amid overall upward movement for Bitcoin and top altcoins.

Polkadot (DOT) holds near $1.50 as upgrade nears

Polkadot’s price shows an intraday range of $1.49-1.54 in early trading during the US session on March 10.

The gains see buyers bid for a retest of recent highs, while holding the critical $1.50 level.

The backdrop to this price action is a scheduled reset of Polkadot’s tokenomics.

A new monetary framework will roll out on March 12, and analysts say anticipation could catalyze fresh momentum for DOT.

The uptick this past week coincided with notable buying as traders positioned ahead of the event.

Specifically, Polkadot’s tokenomics reset will involve the introduction of a 2.1 billion hard cap on DOT supply.

The upgrade targets a 53.6% cut in emissions as well as staking.

ETF buzz has also engulfed Polkadot over the past few days.

This follows the debut of 21Shares’ spot Polkadot ETF, the first US spot DOT ETF that went live on Nasdaq under the ticker TDOT.

The physically backed fund, seeded with $11 million, could strengthen the asset’s appeal as a longer‑term allocation within diversified crypto portfolios.

Polkadot technical analysis

From a technical perspective, DOT’s immediate focus is on converting the $1.50-$1.55 region from resistance into support.

Bulls are eyeing three consecutive green candles on the daily chart and look to have stemmed the downtrend from highs of $1.75 posted in late February.

RSI is neutral near 50, and an upturn could see buyers accelerate gains.

However, after a choppy start to the year, trading around this level means bulls may not be out of the woods yet.

Polkadot Price ChartPolkadot price chart by TradingView

The token may thus trade sideways as consolidation picks pace.

For a breakout, DOT has to achieve an emphatic daily close above $1.55.

A successful breach of resistance at $1.67 amid a bullish retest could trigger follow-through buying.

If this happens, it could open the door to a short-term test of recent local highs around $2.30.

Conversely, failure to hold $1.50 will keep DOT confined within its descending channel. Major support lies around $1.22.

The post Polkadot price outlook: bulls test key resistance near $1.50 appeared first on CoinJournal.

Market Opportunity
Ucan fix life in1day Logo
Ucan fix life in1day Price(1)
$0.0003908
$0.0003908$0.0003908
-7.43%
USD
Ucan fix life in1day (1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11
Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift

Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift

The post Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift appeared on BitcoinEthereumNews.com. RBA Rate Hike: Standard Chartered’s Critical
Share
BitcoinEthereumNews2026/03/12 16:05
X1 EcoChain Partners with Symbiosis to Pioneer Cross-Chain Interoperability Ahead of Mainnet Launch

X1 EcoChain Partners with Symbiosis to Pioneer Cross-Chain Interoperability Ahead of Mainnet Launch

X1 EcoChain and Symbiosis are joining forces, making it possible to move assets seamlessly across 45-plus chains with mainnet launch right around the corner.
Share
Blockchainreporter2026/03/12 16:00